Line et al. [33] reported that low glutamine amounts were associated with older age, advanced-stage cancer, low albumin levels, high carcinoembryonic antigen levels, increased C-reactive protein levels, higher modified Glasgow prognostic scores, and augmented proinflammatory cytokine levels in colorectal cancer-affected patients. The gene discussed is ALB; the disease is cancer.